Cargando…
p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation
Pancreatic cancer is one of the most aggressive and lethal malignancies worldwide, with a very poor prognosis and a five-year survival rate less than 8%. This dismal outcome is largely due to delayed diagnosis, early distant dissemination and resistance to conventional chemo-therapies. Kras mutation...
Autores principales: | Wang, Kai, Baldwin, Graham S, Nikfarjam, Mehrdad, He, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127653/ https://www.ncbi.nlm.nih.gov/pubmed/30197477 http://dx.doi.org/10.3748/wjg.v24.i33.3709 |
Ejemplares similares
-
Depletion of p21-activated kinase 1 up-regulates the immune system of APC(∆14/+) mice and inhibits intestinal tumorigenesis
por: Huynh, Nhi, et al.
Publicado: (2017) -
Cannabinoids Inhibited Pancreatic Cancer via P-21 Activated Kinase 1 Mediated Pathway
por: Yang, Yang, et al.
Publicado: (2020) -
FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabine
por: Yeo, Dannel, et al.
Publicado: (2016) -
Demonstration and biological significance of a gastrin‐P21‐activated kinase 1 feedback loop in colorectal cancer cells
por: Huynh, Nhi, et al.
Publicado: (2014) -
Potential Use of Cannabinoids for the Treatment of Pancreatic Cancer
por: Sharafi, Golnaz, et al.
Publicado: (2019)